Information  X 
Enter a valid email address

Hitachi Capital (UK) (83NN)

  Print      Mail a friend

Thursday 07 November, 2019

Hitachi Capital (UK)

Hitachi Capital Publication of Suppl.Prospcts

RNS Number : 6799S
Hitachi Capital (UK) PLC
07 November 2019
 

[7] November 2019

Hitachi Capital (UK) PLC - Publication of Prospectus

The following prospectus was approved by the Financial Conduct Authority on 7 November 2019 and is available for viewing:

U.S.$5,500,000,000 Euro Note Programme Supplementary Offering Circular dated 7 November 2019

To view the full document, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/6799S_1-2019-11-7.pdf

A copy of the abovementioned document has also been submitted to the National Storage Mechanism and will shortly be available for inspection at: http://www.morningstar.co.uk/uk/NSM.

(To find the above document search under the headline "SUPPLEMENTARY OFFERING CIRCULAR DATED 7 NOVEMBER 2019")

 

For further information, please contact

Samuel Robinson

Hitachi Capital (UK) PLC

Hitachi Capital House

Thorpe Road

Staines-upon-Thames

Surrey TW18 3HP

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above requirement. 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
PSPLDLFBKFFEFBL

a d v e r t i s e m e n t